Sex differences in brain atrophy in multiple sclerosis

Abstract Background Women are more susceptible to multiple sclerosis (MS) than men by a ratio of approximately 3:1. However, being male is a risk factor for worse disability progression. Inflammatory genes have been linked to susceptibility, while neurodegeneration underlies disability progression....

Full description

Bibliographic Details
Main Authors: Rhonda R. Voskuhl, Kevin Patel, Friedemann Paul, Stefan M. Gold, Michael Scheel, Joseph Kuchling, Graham Cooper, Susanna Asseyer, Claudia Chien, Alexander U. Brandt, Cassandra Eve Meyer, Allan MacKenzie-Graham
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Biology of Sex Differences
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13293-020-00326-3
_version_ 1818883147742314496
author Rhonda R. Voskuhl
Kevin Patel
Friedemann Paul
Stefan M. Gold
Michael Scheel
Joseph Kuchling
Graham Cooper
Susanna Asseyer
Claudia Chien
Alexander U. Brandt
Cassandra Eve Meyer
Allan MacKenzie-Graham
author_facet Rhonda R. Voskuhl
Kevin Patel
Friedemann Paul
Stefan M. Gold
Michael Scheel
Joseph Kuchling
Graham Cooper
Susanna Asseyer
Claudia Chien
Alexander U. Brandt
Cassandra Eve Meyer
Allan MacKenzie-Graham
author_sort Rhonda R. Voskuhl
collection DOAJ
description Abstract Background Women are more susceptible to multiple sclerosis (MS) than men by a ratio of approximately 3:1. However, being male is a risk factor for worse disability progression. Inflammatory genes have been linked to susceptibility, while neurodegeneration underlies disability progression. Thus, there appears to be a differential effect of sex on inflammation versus neurodegeneration. Further, gray matter (GM) atrophy is not uniform across the brain in MS, but instead shows regional variation. Here, we study sex differences in neurodegeneration by comparing regional GM atrophy in a cohort of men and women with MS versus their respective age- and sex-matched healthy controls. Methods Voxel-based morphometry (VBM), deep GM substructure volumetry, and cortical thinning were used to examine regional GM atrophy. Results VBM analysis showed deep GM atrophy in the thalamic area in both men and women with MS, whereas men had additional atrophy in the putamen as well as in localized cortical regions. Volumetry confirmed deep GM loss, while localized cortical thinning confirmed GM loss in the cerebral cortex. Further, MS males exhibited worse performance on the 9-hole peg test (9HPT) than MS females. We observed a strong correlation between thalamic volume and 9HPT performance in MS males, but not in MS females. Conclusion More regional GM atrophy was observed in men with MS than women with MS, consistent with previous observations that male sex is a risk factor for worse disease progression.
first_indexed 2024-12-19T15:29:02Z
format Article
id doaj.art-31e56c00d8584ce5924b0a948fedf9a6
institution Directory Open Access Journal
issn 2042-6410
language English
last_indexed 2024-12-19T15:29:02Z
publishDate 2020-08-01
publisher BMC
record_format Article
series Biology of Sex Differences
spelling doaj.art-31e56c00d8584ce5924b0a948fedf9a62022-12-21T20:15:47ZengBMCBiology of Sex Differences2042-64102020-08-0111111010.1186/s13293-020-00326-3Sex differences in brain atrophy in multiple sclerosisRhonda R. Voskuhl0Kevin Patel1Friedemann Paul2Stefan M. Gold3Michael Scheel4Joseph Kuchling5Graham Cooper6Susanna Asseyer7Claudia Chien8Alexander U. Brandt9Cassandra Eve Meyer10Allan MacKenzie-Graham11Department of Neurology, University of California, Los AngelesDepartment of Neurology, University of California, Los AngelesExperimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of HealthInstitute for Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology, Universitätsklinikum Hamburg-EppendorfInstitute of Neuroradiology, Charité – Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of HealthExperimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of HealthExperimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of HealthExperimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of HealthExperimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of HealthNeuroCure Clinical Research Center, Charité – Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of HealthDepartment of Neurology, University of California, Los AngelesDepartment of Neurology, University of California, Los AngelesAbstract Background Women are more susceptible to multiple sclerosis (MS) than men by a ratio of approximately 3:1. However, being male is a risk factor for worse disability progression. Inflammatory genes have been linked to susceptibility, while neurodegeneration underlies disability progression. Thus, there appears to be a differential effect of sex on inflammation versus neurodegeneration. Further, gray matter (GM) atrophy is not uniform across the brain in MS, but instead shows regional variation. Here, we study sex differences in neurodegeneration by comparing regional GM atrophy in a cohort of men and women with MS versus their respective age- and sex-matched healthy controls. Methods Voxel-based morphometry (VBM), deep GM substructure volumetry, and cortical thinning were used to examine regional GM atrophy. Results VBM analysis showed deep GM atrophy in the thalamic area in both men and women with MS, whereas men had additional atrophy in the putamen as well as in localized cortical regions. Volumetry confirmed deep GM loss, while localized cortical thinning confirmed GM loss in the cerebral cortex. Further, MS males exhibited worse performance on the 9-hole peg test (9HPT) than MS females. We observed a strong correlation between thalamic volume and 9HPT performance in MS males, but not in MS females. Conclusion More regional GM atrophy was observed in men with MS than women with MS, consistent with previous observations that male sex is a risk factor for worse disease progression.http://link.springer.com/article/10.1186/s13293-020-00326-3Multiple sclerosisSex differencesNeuroimagingNeurodegenerationDisability progression
spellingShingle Rhonda R. Voskuhl
Kevin Patel
Friedemann Paul
Stefan M. Gold
Michael Scheel
Joseph Kuchling
Graham Cooper
Susanna Asseyer
Claudia Chien
Alexander U. Brandt
Cassandra Eve Meyer
Allan MacKenzie-Graham
Sex differences in brain atrophy in multiple sclerosis
Biology of Sex Differences
Multiple sclerosis
Sex differences
Neuroimaging
Neurodegeneration
Disability progression
title Sex differences in brain atrophy in multiple sclerosis
title_full Sex differences in brain atrophy in multiple sclerosis
title_fullStr Sex differences in brain atrophy in multiple sclerosis
title_full_unstemmed Sex differences in brain atrophy in multiple sclerosis
title_short Sex differences in brain atrophy in multiple sclerosis
title_sort sex differences in brain atrophy in multiple sclerosis
topic Multiple sclerosis
Sex differences
Neuroimaging
Neurodegeneration
Disability progression
url http://link.springer.com/article/10.1186/s13293-020-00326-3
work_keys_str_mv AT rhondarvoskuhl sexdifferencesinbrainatrophyinmultiplesclerosis
AT kevinpatel sexdifferencesinbrainatrophyinmultiplesclerosis
AT friedemannpaul sexdifferencesinbrainatrophyinmultiplesclerosis
AT stefanmgold sexdifferencesinbrainatrophyinmultiplesclerosis
AT michaelscheel sexdifferencesinbrainatrophyinmultiplesclerosis
AT josephkuchling sexdifferencesinbrainatrophyinmultiplesclerosis
AT grahamcooper sexdifferencesinbrainatrophyinmultiplesclerosis
AT susannaasseyer sexdifferencesinbrainatrophyinmultiplesclerosis
AT claudiachien sexdifferencesinbrainatrophyinmultiplesclerosis
AT alexanderubrandt sexdifferencesinbrainatrophyinmultiplesclerosis
AT cassandraevemeyer sexdifferencesinbrainatrophyinmultiplesclerosis
AT allanmackenziegraham sexdifferencesinbrainatrophyinmultiplesclerosis